Mette Rosenkilde

Mette Rosenkilde is a Professor at the Department of Biomedical Sciences (BMI), University of Copenhagen, leading the Molecular Pharmacology Laboratory (MolPharm). Her research focuses on structure-function relationships of 7TM (seven transmembrane) G protein-coupled receptors (GPCRs) and their role in metabolic and neurological diseases.

Key research areas include:

• GIP and GLP-1 receptor pharmacology
• Adhesion GPCR signaling mechanisms
• Drug discovery for obesity and diabetes
• Receptor dynamics in neuroendocrine regulation
• Collaborations with biotech startups (Antag Therapeutics, Synklino)

Selected research trends from her 297+ publications span: GIP receptor antagonists for obesity, adhesion GPCR signaling complexities, and GLP-1 receptor modulation of intracranial pressure. Her work bridges molecular pharmacology and translational medicine.

Collaborations include:

• Antag Therapeutics
• Bainan Biotech
• Synklino
• International research networks across Europe